After hours
You're reading the free version. Trader adds the live tape and alerts. Start tracking

Price with disclosed trades

Daily closes, past year · marks sit on transaction dates, sized by value

2 trades

Disclosure transactions for NRX Pharmaceuticals
Reporting person Filed Transaction Transaction value Source Actions
Abrams Michael S Chief Financial Officer Nov 4, 2026 99-day lag Award Jul 28, 2026 $0 Filed shares x price SEC Form 4 View filing
Javitt Jonathan C CEO And Chairman Nov 4, 2026 99-day lag Award Jul 28, 2026 $0 Filed shares x price SEC Form 4 View filing
Abrams Michael S Chief Financial Officer
Award
Calculated transaction value
$0 75,000 shares @ $0
Traded
Jul 28, 2026
Filed
Nov 4, 2026
Javitt Jonathan C CEO And Chairman
Award
Calculated transaction value
$0 150,000 shares @ $0
Traded
Jul 28, 2026
Filed
Nov 4, 2026